Literature DB >> 29107047

Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.

Huijun Chen1, Yipshu Pui1, Chengyu Liu1, Zhen Chen1, Ching-Chiang Su2, Michael Hageman3, Munir Hussain4, Roy Haskell5, Kevin Stefanski2, Kimberly Foster2, Olafur Gudmundsson2, Feng Qian6.   

Abstract

Amorphous phase separation (APS) is commonly observed in amorphous solid dispersions (ASD) when exposed to moisture. The objective of this study was to investigate: (1) the phase behavior of amorphous solid dispersions composed of a poorly water-soluble drug with extremely low crystallization propensity, BMS-817399, and PVP, following exposure to different relative humidity (RH), and (2) the impact of phase separation on the intrinsic dissolution rate of amorphous solid dispersion. Drug-polymer interaction was confirmed in ASDs at different drug loading using infrared (IR) spectroscopy and water vapor sorption analysis. It was found that the drug-polymer interaction could persist at low RH (≤75% RH) but was disrupted after exposure to high RH, with the advent of phase separation. Surface morphology and composition of 40/60 ASD at micro-/nano-scale before and after exposure to 95% RH were also compared. It was found that hydrophobic drug enriched on the surface of ASD after APS. However, for the 40/60 ASD system, the intrinsic dissolution rate of amorphous drug was hardly affected by the phase behavior of ASD, which may be partially attributed to the low crystallization tendency of amorphous BMS-817399 and enriched drug amount on the surface of ASD. Intrinsic dissolution rate of PVP decreased resulting from APS, leading to a lower concentration in the dissolution medium, but supersaturation maintenance was not anticipated to be altered after phase separation due to the limited ability of PVP to inhibit drug precipitation and prolong the supersaturation of drug in solution. This study indicated that for compounds with low crystallization propensity and high hydrophobicity, the risk of moisture-induced APS is high but such phase separation may not have profound impact on the drug dissolution performance of ASDs. Therefore, application of ASD technology on slow crystallizers could incur low risks not only in physical stability but also in dissolution performance.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amorphous; dissolution rate; drug-excipient interaction; physical stability; solid dispersion

Mesh:

Substances:

Year:  2017        PMID: 29107047     DOI: 10.1016/j.xphs.2017.10.028

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range.

Authors:  Yiwei Tian; Kaijie Qian; Esther Jacobs; Esther Amstad; David S Jones; Lorenzo Stella; Gavin P Andrews
Journal:  Pharmaceutics       Date:  2019-08-19       Impact factor: 6.321

2.  Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability.

Authors:  Zhaomeng Wang; Mengchi Sun; Tian Liu; Zisen Gao; Qing Ye; Xiao Tan; Yanxian Hou; Jin Sun; Dun Wang; Zhonggui He
Journal:  Asian J Pharm Sci       Date:  2018-11-14       Impact factor: 6.598

3.  Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions.

Authors:  Maciej Nowak; Maciej Gajda; Przemysław Baranowski; Patrycja Szymczyk; Bożena Karolewicz; Karol P Nartowski
Journal:  Pharmaceutics       Date:  2019-12-20       Impact factor: 6.321

Review 4.  Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology.

Authors:  Athira R Nair; Yarlagadda Dani Lakshman; Vullendula Sai Krishna Anand; K S Navya Sree; Krishnamurthy Bhat; Swapnil J Dengale
Journal:  AAPS PharmSciTech       Date:  2020-11-08       Impact factor: 3.246

Review 5.  Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.

Authors:  Israel Rodríguez; Ritika Gautam; Arthur D Tinoco
Journal:  Biomimetics (Basel)       Date:  2020-12-30

6.  Exploring the Role of Surfactants in Enhancing Drug Release from Amorphous Solid Dispersions at Higher Drug Loadings.

Authors:  Sugandha Saboo; Pradnya Bapat; Dana E Moseson; Umesh S Kestur; Lynne S Taylor
Journal:  Pharmaceutics       Date:  2021-05-17       Impact factor: 6.321

7.  Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.

Authors:  Na Li; Jonathan L Cape; Bharat R Mankani; Dmitry Y Zemlyanov; Kimberly B Shepard; Michael M Morgen; Lynne S Taylor
Journal:  Mol Pharm       Date:  2020-09-24       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.